Access cutting-edge schizophrenia treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access schizophrenia specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related schizophrenia treatment provided free
The CLOZAPINE study is designed as a multisite study across 5 sites and is a clinical trial, involving human participants who are prospectively assigned to an intervention. The study will utilize a stringent randomized, double-blinded, parallel group clinical trial design. B2 group will serve as psychosis control with risperidone as medication control. The study is designed to evaluate effect of clozapine on the B1 participants, and the effect that will be evaluated is a biomedical outcome. The
Sponsor: University of Texas Southwestern Medical Center
Check if you qualify for this schizophrenia clinical trial in Chicago, IL
If you're searching for schizophrenia treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced schizophrenia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.